Rhythm Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -1.35 | -100% |
| P/S |
|
34.52 | 33.77 | 2.25% |
|
|
| P/BV |
|
15.75 | 4.83 | 226.15% |
|
|
| P/FCF |
|
-7.31 | 61 | -111.98% |
|
|
| Ev/Ebitda |
|
-15.52 | -22.17 | -30% |
|
|
| Ev/S |
|
33.76 | 22.57 | 49.58% |
|
|
| Ev/FCF |
|
-19.19 | 68.76 | -127.91% |
|
|
| E/P |
|
-0.1856 | 0.0178 | -1144.24% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-217.58 | 4.97 | -4475.95% | -99140.5 | -99.78% |
| ROE |
|
-108.79 | 9.61 | -1231.85% |
|
|
| ROA |
|
-55.5 | 0.3443 | -16221.96% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-238.52 | -25.17 | 847.63% |
|
|
| ROCE |
|
-100.27 | 15.45 | -749.03% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0075 | -3.68 | -99.8% | -0.0098 | -23.9% |
| Nеt Debt/Ebitda |
|
0.3492 | -3.44 | -110.16% |
|
|
| Debt/Ratio |
|
0.0038 | 0.1986 | -98.09% |
|
|
| Debt/Equity |
|
0.5727 | 1.66 | -65.55% |
|
|
| Debt/Net Income |
|
-0.0068 | 10.32 | -100.07% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
221122.86 | -57.64 | -383727.45% | ||
| Growth impulse Ebitda in 5 years |
|
15.39 | -90.94 | -116.92% | ||
| Growth impulse Net Income in 5 years |
|
37.18 | -97.8 | -138.02% | ||
| Growth impulse FCF in 5 years |
|
7.98 | -108.72 | -107.34% | ||
| Growth impulse EPS in 5 years |
|
-13.37 | -142.05 | -90.59% |
IP Score
3.3/10
